AFA-281: Clinical Trials

1 trial of AFA-281, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow AFA-281: new trials by email Literature Review of AFA-281 trials Research Report on AFA-281

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase I Single Ascending Dose and Multiple Ascending Doses of Oral AFA-281 in Healthy Volunteers
AFA-281 - Pain, Neuropathic, Pain, Inflammatory
Phase 1CompletedAfasci Inc642023-04-112025-10-21

Conditions studied

Neuralgia (1)  ·  Pain (1)

Sponsors

Afasci Inc (1)

Countries

United States (1)

Top investigators

Xinmin Xie, MD, PhD (1)